On the other hand, in the new consensus recommendations for the study of monoclonal gammopathies from the Spanish Society of Laboratory Medicine and the Spanish Society of Haematology and Hemotherapy, urine analysis is not recommended in the screening for monoclonal gammopathies, but it is recommended when a M-protein in serum is detected to complete the study [6]. The gene discussed is MYOM2; the disease is monoclonal gammopathy.